99%+ PURITY VERIFIED·INDEPENDENT LAB TESTING·SHIPS WITHIN CANADA·DISCREET EXPRESS DELIVERY
JA Performance Peptides
JA Performance
Peptides
Back to Protocols
Multi-Peptide Blend80 mg

KLOW (80 mg Vial)

Complete reconstitution and dosing protocol

Quick Reference

VIAL SIZE80 mg total (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg)
RECONSTITUTION3 mL bacteriostatic water
CONCENTRATION26.7 mg/mL total blend
ROUTESubcutaneous injection
FREQUENCYOnce daily
CYCLE LENGTH8–12 weeks
DOSE RANGE0.1–0.2 mL per injection
STORAGE−20 °C long-term

Overview

KLOW is a four-peptide blend administered subcutaneously once daily. This protocol uses a 3 mL reconstitution for a total blend concentration of 26.7 mg/mL. Each 0.1 mL injection delivers proportional amounts of all four components: GHK-Cu, BPC-157, TB-500, and KPV.

Dosing & Reconstitution Guide

PhaseDaily DoseUnitsVolume
Standard Dose0.1 mL daily10 units0.10 mL
Elevated Dose0.2 mL daily20 units0.20 mL

Reconstitution Instructions

1.

Allow vial and bacteriostatic water to reach room temperature (15–30 minutes).

2.

Wipe each rubber stopper with an alcohol swab; allow to air dry.

3.

Draw 3 mL of bacteriostatic water with a sterile syringe.

4.

Slowly inject water along the inside wall of the vial — never spray directly onto the powder.

5.

Gently swirl or roll the vial between palms — never shake.

6.

Allow to dissolve completely (2–3 minutes); solution may have a faint blue tint from GHK-Cu.

This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

  • Peptide Vials (KLOW, 80 mg): 2–3 vials
  • Insulin Syringes (U-100): 56 syringes
  • Bacteriostatic Water (10 mL): 1 bottle
  • Alcohol Swabs: 2 × 100-count boxes

Dosing Protocol

Standard Research Dose

0.1 mL once daily subcutaneous injection. Draw to 10 units on a U-100 insulin syringe. Each dose delivers approximately: GHK-Cu 1.67 mg, BPC-157 333 mcg, TB-500 333 mcg, KPV 333 mcg.

Elevated Research Dose

0.2 mL once daily subcutaneous injection. Draw to 20 units. Delivers double the standard dose of each component.

Cycle Structure

Run for 8–12 weeks continuously. Follow with a 2–4 week break before repeating.

Storage & Handling

Important Notes